Madrigal Pharmaceuticals, Inc.
MDGL
$579.89
$6.741.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.11B | 797.02M | 843.07M | 926.25M | 998.63M |
| Total Receivables | 113.29M | 79.23M | 61.43M | 53.82M | 30.46M |
| Inventory | 69.32M | 63.50M | 55.24M | 34.07M | 8.72M |
| Prepaid Expenses | 49.33M | 58.60M | 23.24M | 13.79M | 20.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M |
| Total Current Assets | 1.35B | 1.00B | 987.98M | 1.03B | 1.06B |
|
|
|||||
| Total Current Assets | 1.35B | 1.00B | 987.98M | 1.03B | 1.06B |
| Net Property, Plant & Equipment | 8.30M | 7.48M | 4.01M | 4.59M | 4.78M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 7.48M | 4.55M | 4.64M | 4.73M | 4.82M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.36B | 1.02B | 996.63M | 1.04B | 1.07B |
|
|
|||||
| Total Accounts Payable | 44.94M | 37.98M | 42.06M | 43.60M | 45.97M |
| Total Accrued Expenses | 345.38M | 157.48M | 124.17M | 124.70M | 131.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.08M | 1.05M | 1.02M | 983.00K | 878.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 391.41M | 196.50M | 167.24M | 169.28M | 177.85M |
|
|
|||||
| Total Current Liabilities | 391.41M | 196.50M | 167.24M | 169.28M | 177.85M |
| Long-Term Debt | 339.75M | 118.38M | 118.01M | 117.57M | 117.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.57M | 4.52M | 750.00K | 1.02M | 1.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 736.73M | 319.40M | 285.99M | 287.86M | 296.11M |
|
|
|||||
| Common Stock & APIC | 2.66B | 2.61B | 2.59B | 2.56B | 2.52B |
| Retained Earnings | -2.03B | -1.92B | -1.88B | -1.80B | -1.74B |
| Treasury Stock & Other | 1.07M | 1.11M | 389.00K | 468.00K | 1.27M |
| Total Common Equity | 625.73M | 695.98M | 710.64M | 754.38M | 777.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 625.73M | 695.98M | 710.64M | 754.38M | 777.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 625.73M | 695.98M | 710.64M | 754.38M | 777.16M |
|
|
|||||